Vantiq, RoviSys: COVID-19 shows need for advanced pharma tech
Two leaders from advanced tech firms share lessons learned during the pandemic, pointing toward a need for technology to drive the future of pharma.
Headlines
Global Industry News
-
J&J receives EU approval for Ebola vaccine
from BioPharma-Reporter.com
-
Sarepta licenses therapy to boost gene therapies
from BioPharma-Reporter.com
-
Tesla’s ‘side project’ building RNA microfactories for CureVac
from BioPharma-Reporter.com
-
Takeda expands in gene therapy with $900m R&D deal
from BioPharma-Reporter.com
Hot Topics
-
Noxopharm launches Phase I COVID-19 program in Europe
Clinical evolution
-
LMC Manna Research survey shares trial patients' COVID-19 views
Patient centricity
-
ERT, Inofab join forces on decentralized respiratory trials
Patient centricity
-
Parexel, TriNetX partner to advance RWD in clinical trials
Patient centricity
Spotlight
Follow us
Products
View moreWebinars
Featured Suppliers
All suppliers-
Advarra |
Ajinomoto Bio-Pharma Services |
AMRI |
Baxter BioPharma Solutions |
BioContinuum™ Platform - MilliporeSigma |
Clinical Ink |
EVERSANA |
Frontage Laboratories |
Laurus Labs Ltd. |
Marken |
Merck KGaA, Darmstadt, Germany |
PRA Health Sciences |
Q2 Solutions |
Vetter Pharma International GmbH |
Yourway